Trimbow (beclometasone/formoterol/glycopyrrolate) - Chiesi
Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting (STRENGTH) (clinicaltrials.gov) - Mar 25, 2026 - P=N/A | N=200 | Recruiting | Sponsor: Chiesi Slovenija, d.o.o. 
New trial • Real-world evidence • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
http://clinicaltrials.gov/ct2/show/NCT07489911
 
Mar 25, 2026
 
Prev Next